MAPKAP Kinase 5 anticorps (pSer93) (Cy3)

N° du produit ABIN710564

L’anticorps anti-MAPKAP Kinase 5 Polyclonal produit chez le Lapin a été validé pour WB, IF (cc) et IF (p). Il convient pour la détection de MAPKAP Kinase 5 dans des échantillons provenant de Humain, Souris et Rat. }

Aperçu rapide pour MAPKAP Kinase 5 anticorps (pSer93) (Cy3) (ABIN710564)

Antigène: MAPKAP Kinase 5 (MAPKAPK5) (Mitogen-Activated Protein Kinase-Activated Protein Kinase 5 (MAPKAPK5))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MAPKAP Kinase 5 est conjugé à/à la Cy3

Application: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Détail du produit anti-MAPKAP Kinase 5 anticorps (Cy3)

Épitope: pSer93

Réactivité croisée: Humain, Souris, Rat

Homologie: Dog,Cow,Horse,Chicken

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic phosphopeptide derived from human MAPKAPK5 around the phosphorylation site of Ser93

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur MAPKAP Kinase 5

Antigène: MAPKAP Kinase 5 (MAPKAPK5) (Mitogen-Activated Protein Kinase-Activated Protein Kinase 5 (MAPKAPK5))

Autre désignation: MAPKAPK5

Sujet:

Synonyms: MAPKAPK5phospho S93, MAP kinase-activated protein kinase 5, MAPKAP kinase 5, MAPKAPK5, mitogen-activated protein kinase-activated protein kinase 5, p38-regulated/activated protein kinase.

Background: The serine/threonine kinase PRAK is activated in response to cellular stress and proinflammatory cytokines, through its phosphorylation by MAP kinases including MAPK1/ERK, MAPK14/p38 alpha, and MAPK11/p38 beta. PRAK has been reported to have a putative tumor suppressor function by mediating senescence upon activation by p38 in response to oncogenic ras. It is thought that phosphorylation of p53 by PRAK following activation of p38 MAPK by ras plays an important role in ras induced senescence and tumor suppression.

Poids moléculaire: 54kDa

ID gène: 8550

Pathways: Signalisation MAPK